1275 related articles for article (PubMed ID: 18492606)
21. N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
Benediktsdóttir BE; Gudjónsson T; Baldursson Ó; Másson M
Eur J Pharm Biopharm; 2014 Jan; 86(1):55-63. PubMed ID: 23608635
[TBL] [Abstract][Full Text] [Related]
22. Transport of octreotide and evaluation of mechanism of opening the paracellular tight junctions using superporous hydrogel polymers in Caco-2 cell monolayers.
Dorkoosh FA; Broekhuizen CA; Borchard G; Rafiee-Tehrani M; Verhoef JC; Junginger HE
J Pharm Sci; 2004 Mar; 93(3):743-52. PubMed ID: 14762912
[TBL] [Abstract][Full Text] [Related]
23. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.
Sahni JK; Chopra S; Ahmad FJ; Khar RK
J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113
[TBL] [Abstract][Full Text] [Related]
24. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
27. Transmucosal macromolecular drug delivery.
Prego C; García M; Torres D; Alonso MJ
J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
[TBL] [Abstract][Full Text] [Related]
28. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
Zambito Y; Zaino C; Uccello-Barretta G; Balzano F; Di Colo G
Eur J Pharm Sci; 2008 Apr; 33(4-5):343-50. PubMed ID: 18296036
[TBL] [Abstract][Full Text] [Related]
29. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
30. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
du Plessis LH; Kotzé AF; Junginger HE
Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
[TBL] [Abstract][Full Text] [Related]
31. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
Biomacromolecules; 2009 Feb; 10(2):243-9. PubMed ID: 19117404
[TBL] [Abstract][Full Text] [Related]
32. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.
Thanou MM; Kotzé AF; Scharringhausen T; Luessen HL; de Boer AG; Verhoef JC; Junginger HE
J Control Release; 2000 Feb; 64(1-3):15-25. PubMed ID: 10640642
[TBL] [Abstract][Full Text] [Related]
33. Intestinal drug transport enhancement by Aloe vera.
Chen W; Lu Z; Viljoen A; Hamman J
Planta Med; 2009 May; 75(6):587-95. PubMed ID: 19214949
[TBL] [Abstract][Full Text] [Related]
34. In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles.
Liu Y; Di Zang H; Kong M; Ma FK; Dang QF; Cheng XJ; Ji QX; Chen XG
Carbohydr Polym; 2012 Jun; 89(2):453-60. PubMed ID: 24750743
[TBL] [Abstract][Full Text] [Related]
35. Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes.
Moghassemi S; Parnian E; Hakamivala A; Darzianiazizi M; Vardanjani MM; Kashanian S; Larijani B; Omidfar K
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():333-40. PubMed ID: 25491995
[TBL] [Abstract][Full Text] [Related]
36. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
37. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
38. Permeability enhancing effects of the alkylglycoside, octylglucoside, on insulin permeation across epithelial membrane in vitro.
Tirumalasetty PP; Eley JG
J Pharm Pharm Sci; 2006; 9(1):32-9. PubMed ID: 16849006
[TBL] [Abstract][Full Text] [Related]
39. N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells.
Hamman JH; Schultz CM; Kotzé AF
Drug Dev Ind Pharm; 2003 Feb; 29(2):161-72. PubMed ID: 12648013
[TBL] [Abstract][Full Text] [Related]
40. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
